These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19923910)

  • 1. The combination of 5-fluorouracil plus p53 pathway restoration is associated with depletion of p53-deficient or mutant p53-expressing putative colon cancer stem cells.
    Huang C; Zhang XM; Tavaluc RT; Hart LS; Dicker DT; Wang W; El-Deiry WS
    Cancer Biol Ther; 2009 Nov; 8(22):2186-93. PubMed ID: 19923910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visualization and enrichment of live putative cancer stem cell populations following p53 inactivation or Bax deletion using non-toxic fluorescent dyes.
    Allen JE; Hart LS; Dicker DT; Wang W; El-Deiry WS
    Cancer Biol Ther; 2009 Nov; 8(22):2194-205. PubMed ID: 19923899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53.
    Zhang S; Zhou L; Hong B; van den Heuvel AP; Prabhu VV; Warfel NA; Kline CL; Dicker DT; Kopelovich L; El-Deiry WS
    Cancer Res; 2015 Sep; 75(18):3842-52. PubMed ID: 26294215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-genotoxic anti-neoplastic effects of ellipticine derivative NSC176327 in p53-deficient human colon carcinoma cells involve stimulation of p73.
    Lu C; Wang W; El-Deiry WS
    Cancer Biol Ther; 2008 Dec; 7(12):2039-46. PubMed ID: 19106635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p73 cooperates with DNA damage agents to induce apoptosis in MCF7 cells in a p53-dependent manner.
    Zhu J; Nozell S; Wang J; Jiang J; Zhou W; Chen X
    Oncogene; 2001 Jul; 20(30):4050-7. PubMed ID: 11494133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 dependence and apoptosis in response to FP treatment with p53-transfected colon cancer cell lines by use of thin layer collagen gel.
    Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S
    Oncol Rep; 2004 Aug; 12(2):357-61. PubMed ID: 15254702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of the small heat shock protein alphaB-crystallin by genotoxic stress is mediated by p53 and p73.
    Evans JR; Bosman JD; Brown-Endres L; Yehiely F; Cryns VL
    Breast Cancer Res Treat; 2010 Jul; 122(1):159-68. PubMed ID: 19777343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small-molecule modulators of p53 family signaling and antitumor effects in p53-deficient human colon tumor xenografts.
    Wang W; Kim SH; El-Deiry WS
    Proc Natl Acad Sci U S A; 2006 Jul; 103(29):11003-8. PubMed ID: 16835297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D mediates its action in human colon carcinoma cells in a calcium-sensing receptor-dependent manner: downregulates malignant cell behavior and the expression of thymidylate synthase and survivin and promotes cellular sensitivity to 5-FU.
    Liu G; Hu X; Chakrabarty S
    Int J Cancer; 2010 Feb; 126(3):631-9. PubMed ID: 19621386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mutant p53-conformation modifying drug, CP-31398, can induce apoptosis of human cancer cells and can stabilize wild-type p53 protein.
    Takimoto R; Wang W; Dicker DT; Rastinejad F; Lyssikatos J; el-Deiry WS
    Cancer Biol Ther; 2002; 1(1):47-55. PubMed ID: 12174820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents.
    Mahyar-Roemer M; Roemer K
    Oncogene; 2001 Jun; 20(26):3387-98. PubMed ID: 11423989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The p53-family members p63 and p73 inhibit insulin-like growth factor-I receptor gene expression in colon cancer cells.
    Nahor I; Abramovitch S; Engeland K; Werner H
    Growth Horm IGF Res; 2005 Dec; 15(6):388-96. PubMed ID: 16181796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cyclin A kinase activity in E2F-1 chemogene therapy of colon cancer.
    Elliott MJ; Baker JD; Dong YB; Yang HL; Gleason JF; McMasters KM
    Tumour Biol; 2002; 23(6):324-36. PubMed ID: 12677090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter specificity and stability control of the p53-related protein p73.
    Lee CW; La Thangue NB
    Oncogene; 1999 Jul; 18(29):4171-81. PubMed ID: 10435630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of mitochondrial p53 to dominant inhibition.
    Heyne K; Schmitt K; Mueller D; Armbruester V; Mestres P; Roemer K
    Mol Cancer; 2008 Jun; 7():54. PubMed ID: 18547443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rescue of mutant p53 transcription function by ellipticine.
    Peng Y; Li C; Chen L; Sebti S; Chen J
    Oncogene; 2003 Jul; 22(29):4478-87. PubMed ID: 12881704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming hypoxia-induced apoptotic resistance through combinatorial inhibition of GSK-3β and CDK1.
    Mayes PA; Dolloff NG; Daniel CJ; Liu JJ; Hart LS; Kuribayashi K; Allen JE; Jee DI; Dorsey JF; Liu YY; Dicker DT; Brown JM; Furth EE; Klein PS; Sears RC; El-Deiry WS
    Cancer Res; 2011 Aug; 71(15):5265-75. PubMed ID: 21646472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p73 beta-expressing recombinant adenovirus: a potential anticancer agent.
    Das S; Nama S; Antony S; Somasundaram K
    Cancer Gene Ther; 2005 Apr; 12(4):417-26. PubMed ID: 15678153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilization of p53 by CP-31398 inhibits ubiquitination without altering phosphorylation at serine 15 or 20 or MDM2 binding.
    Wang W; Takimoto R; Rastinejad F; El-Deiry WS
    Mol Cell Biol; 2003 Mar; 23(6):2171-81. PubMed ID: 12612087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
    Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
    Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.